This invention relates to devices intended for removing acute blockages from blood vessels. The invention especially relates to means of rendering such devices visible under x-ray or fluoroscopy. Acute obstructions may include clot, misplaced devices, migrated devices, large emboli and the like. Thromboembolism occurs when part or all of a thrombus breaks away from the blood vessel wall. This clot (now called an embolus) is then carried in the direction of blood flow. An ischemic stroke may result if the clot lodges in the cerebral vasculature. A pulmonary embolism may result if the clot originates in the venous system or in the right side of the heart and lodges in a pulmonary artery or branch thereof. Clots may also develop and block vessels locally without being released in the form of an embolus—this mechanism is common in the formation of coronary blockages. The invention is particularly suited to removing clot from cerebral arteries in patients suffering acute ischemic stroke (AIS), from coronary native or graft vessels in patients suffering from myocardial infarction (MI), and from pulmonary arteries in patients suffering from pulmonary embolism (PE) and from other peripheral arterial and venous vessels in which clot is causing an occlusion.
Clot retrieval devices comprising a self-expanding Nitinol stent-like member disposed at the end of a long shaft are commonly used to remove clot from blood vessels, particularly from patients suffering from acute ischemic stroke. These devices are typically provided with small marker bands at either end of the self-expanding member which help to indicate the device's position. It would be very beneficial to a physician to be able to see the full expandable body of such a device under fluoroscopy, and thus receive visual information on the device's condition as rather than simply its position. Clot retrieval procedures are conducted under an x-ray field in order to allow the user visualise the anatomy and at a minimum the device position during a procedure. It is desirable, and enhances the user experience to be able to visualise the device state as well as position structure during a procedure, for example if the device is in an expanded configuration or a collapsed configuration. This means that the radiopaque sections must move closer to the device axis in a collapsed configuration and further from a device axis in an expanded configuration. It is generally desirable to make interventional devices such as clot retrieval devices more flexible and lower profile to improve deliverability in interventional procedures. This may be achieved by reducing the dimensions for device features, and the level of contrast seen under x-ray is generally reduced as the device dimensions are reduced. Radiopaque materials generally comprise noble metals such as gold, tantalum, tungsten, platinum, iridium and the like, and generally have poor elastic recovery from a strained condition and are therefore not optimal material for devices, particularly for the regions of these devices undergoing high strain in moving from a collapsed to an expanded state and vice versa. Radiopaque materials may be added through coating a structure comprising a highly recoverable elastic material such as Nitinol, but coating the entire structure has a dampening effect that inhibits device performance.
This invention overcomes limitations associated with the dampening effect of adding radiopaque material to an expandable clot retrieval device, while making the structure sufficiently radiopaque to allow full visualisation of the device condition as well as position.
Various devices and method are described in our PCT/IE2012/000011 which was published under the number WO2012/120490A. This PCT application claims the benefit of U.S. Provisional 61/450,810, filed Mar. 9, 2011 and U.S. Provisional 61/552,130 filed Oct. 27, 2011. The corresponding U.S. National stage is U.S. application Ser. No. 13/823,060 filed on Mar. 13, 2013. The entire contents of all of the above-listed applications are herein incorporated by reference.
This invention is particularly applicable to clot retrieval devices comprising expandable bodies made from a metallic framework. Such a framework might be a Nitinol framework of interconnected struts, formed by laser (or otherwise) cutting a tube or sheet of material, and may thus comprise a structure with a pattern of strut features and connector features. In some embodiments the clot retrieval device may comprise an inner expandable member and an outer expandable member, which may define a flow lumen through a clot and engage a clot.
In order to go from a collapsed to an expanded configuration, portions of the device undergo recoverable deformation and varying levels of strain. Some portions require a higher level of recoverable strain than others in order to work effectively. Where the framework or expandable member comprises a pattern of strut features and connector features, the struts typically comprise inflection regions or connection regions generally referred to as crowns, which typically experience higher strain than the struts or connectors when the device is collapsed or expanded.
The term detector is generally referred to as the part of the equipment which collects the beam for processing into useful images, and can include for example flat panel detectors or image intensifiers. X-ray beams are filtered through an anti-scatter grid during processing. This filters out scattered beams which deflect significantly from the trajectory of the source beam, and beams less significantly deflected off the original trajectory pass through the anti-scatter grid creating areas of overlap between non-scattered photon beams and scattered photon beams, referred to herein as shadow areas.
In an embodiment of this invention discrete markers are placed in low strain regions of the clot retrieval device members, and high strain regions comprise a super elastic material with little or no radiopaque material.
In use, it is desirable to maximise visibility and therefore maximise the area and volume of radiopaque markers located in the clot retrieval device. Increasing the ratio of radiopaque material to Nitinol generally improves radiopacity. For the effective operation of the device in moving between expanded and collapsed configurations, it is desirable to maintain a ratio of Nitinol to radiopaque material such that strain levels from an expanded to a collapsed configuration are substantially in the elastic region. This creates a conflict of requirements, and the solutions provided herein overcome this conflict.
Discrete markers placed in close proximity create overlapping shadow areas, referred to as intersection zones herein, which give the illusion under x-ray imaging of a continuous marker thereby providing fuller visual information to the user in an x-ray image.
Various embodiments of the invention are described in more detail below. Within these descriptions various terms for each portion of the devices may be interchangeably used. Each of the described embodiments are followed by a list of further qualifications (preceded by the word “wherein”) to describe even more detailed versions of the preceding headline embodiment. It is intended that any of these qualifications may be combined with any of the headline embodiments, but to maintain clarity and conciseness not all of the possible permutations have been listed.
According to the invention there is provided a clot retrieval device comprising an elongate shaft and an expandable clot engaging element on the shaft, the clot engaging element comprising a framework formed from a substrate material and having a plurality of struts and crowns, at least some of the struts comprising at least one widened portion of the substrate material to provide enhanced radiopacity.
In one embodiment the strut comprises a plurality of widened portions which are spaced-apart along a length of the strut.
The widened portion of the strut may be at least 50%, optionally at least 75%, optionally at least 100%, optionally at least 125%, optionally at least 150%, optionally at least 175%, optionally at least 200%, optionally at least 300% wider than the regions along the length of the strut between the widened portions.
The widened portions may have a length which is less than 100%, optionally less than 75%, optionally less than 50%, optionally less than 25% of the length of the regions of the strut between the widened portions.
The length of the regions of the strut between the widened portions may be greater than 300%, optionally greater than 400%, optionally greater than 500%, optionally greater than 600%, optionally greater than 700%, optionally greater than 800%, optionally greater than 900% of the width of the strut.
In one embodiment the clot engaging element is cut from a tube of uniform thickness.
In one embodiment wherein at least a portion of the framework is coated with a radiopaque material.
In one embodiment the substrate material is a superelastic material such as Nitinol or other super or pseudo elastic metallic alloy.
In one case the coating material is Gold, Tantalum, Tungsten, Platinum or an alloy of one of these elements or other dense element or alloy containing one or more radiodense elements.
In one embodiment the coating material comprises a polymer or adhesive filled with a dense or high atomic number material such as Barium Sulphate, Bismuth SubCarbonate, Barium OxyChloride, Gold, Tungsten, Platinum or Tantalum.
In one case the coating material is applied using an electroplating process, a dipping process, a plasma deposition process, an electrostatic process, a dip or spray coating process, a sputtering process, a soldering process, a cladding process or a drawing process.
The substrate material may have a density of less than 10 g/cm3, less than 8 g/cm3.
The coating material may have a density of more than 10 g/cm3, more than 15 g/cm3, more than 18 g/cm3.
One embodiment of a device of this invention comprises a clot retrieval device comprising an elongate shaft and an expandable section, the expandable section comprising a framework of interconnected strut elements, the connection region between adjacent strut elements comprising crown elements, said framework formed from a substrate material, at least a portion of a plurality of said strut elements coated with a coating material, and at least a portion of a plurality of said crown elements not coated with said coating material.
The substrate material may have a density of less than 10 g/cm3, less than 8 g/cm3.
The coating material may have a density of more than 10 g/cm3, more than 15 g/cm3, more than 18 g/cm3.
In one embodiment the substrate material is a superelastic material such as Nitinol or other super or pseudo elastic metallic alloy.
In one case the coating material is Gold, Tantalum, Tungsten, Platinum or an alloy of one of these elements or other dense element or alloy containing one or more radiodense elements.
In one embodiment the coating material comprises a polymer or adhesive filled with a dense or high atomic number material such as Barium Sulphate, Bismuth SubCarbonate, Barium OxyChloride, Gold, Tungsten, Platinum or Tantalum.
In one case the coating material is applied using an electroplating process, a dipping process, a plasma deposition process, an electrostatic process, a dip or spray coating process, a sputtering process, a soldering process, a cladding process or a drawing process.
Another aspect of this invention comprises a method of manufacturing the expandable body of a clot retrieval device, the expandable body comprising a substrate material and a coating material, the method comprising:
In one embodiment the first step comprises an electroplating process, a dipping process, a plasma deposition process, an electrostatic process, a dip or spray coating process, a sputtering process, a soldering process, a cladding process or a drawing process.
In one case the second step comprises a grinding process, a polishing process, a buffing process, an etching process, a laser cutting or laser ablation process.
In one embodiment the third step comprises a laser cutting process, a wire cutting process, a water jet cutting process, a machining process or an etching process.
In one case the coating material is Gold, Tantalum, Tungsten, Platinum or an alloy of one of these elements or other dense element or alloy containing one or more radiodense elements.
In one embodiment the coating material comprises a polymer or adhesive filled with a dense or high atomic number material such as Barium Sulphate, Bismuth SubCarbonate, Barium OxyChloride, Gold, Tungsten, Platinum or Tantalum.
In one case the substrate material comprises Nitinol, or an alloy of Nitinol or another super or pseudo elastic alloy.
In one embodiment the interconnected pattern comprises a plurality of strut elements and connector elements.
In one case the interconnected pattern of the clot retrieval device comprises an expanded state and a collapsed state.
In one embodiment the second step removes at least a portion of the coating from those areas of the interconnected pattern which experience the highest strain in moving from the expanded state to the collapsed state, and/or from the collapsed state to the expanded state.
In one case the strut elements terminate in crown elements.
In one embodiment the second step removes some or all of the coating from the crown elements.
In one case the second step removes some or all of the coating from discrete sections of the strut elements; in one embodiment these discrete sections comprising stripes across the width of the struts.
Another embodiment of a device of this invention comprises a clot retrieval device comprising an elongate shaft and an expandable section, the expandable section formed from a substrate material, at least a portion of the substrate material coated with a first coating material and at least a portion of the first coating material coated with a second coating material.
In one case the substrate material is a superelastic material such as Nitinol or other super or pseudo elastic metallic alloy.
In one embodiment the first coating material is Gold, Tantalum, Tungsten, Platinum or an alloy of one of these elements or other dense element or alloy containing one or more radiodense elements.
In one case the first coating material is applied by a plasma deposition process, an electrostatic process, a dip or spray coating process, a sputtering process, a sputtering process using a cylindrical magnetron, a soldering process, a cladding process or a drawing process.
In one embodiment the first coating material comprises a porous or non-porous columnar structure.
In one case the first coating material comprises a porous columnar structure, comprising generally independent columns of the coating material which extend substantially perpendicularly to the substrate surface.
In one embodiment said columns have a first end and a second end, said first end being adjacent the substrate surface, and the spacing between the second ends of adjacent columns varying with deformation of the substrate material/expandable body.
In one case the second ends of the first coating material define an outer surface, and said outer surface is a rough surface.
In one embodiment the second coating material comprises a smooth surface, and/or a soft surface. In one case the second coating material is a polymeric material.
In one embodiment the elastic modulus of the second coating material is lower than that of the first coating material.
In one case the elastic modulus of the second coating material is lower than that of the substrate material.
In one embodiment the elastic modulus of the second coating material is less than 50% of that of the first coating material and/or substrate material.
In one case the elastic modulus of the second coating material is less than 40% of that of the first coating material and/or substrate material.
In one embodiment the elastic modulus of the second coating material is less than 30% of that of the first coating material and/or substrate material.
In one case the elastic modulus of the second coating material is less than 20% of that of the first coating material and/or substrate material.
In one embodiment the elastic modulus of the second coating material is less than 10% of that of the first coating material and/or substrate material.
In one case the second coating material is a hydrophilic material or a hydrogel.
In one embodiment the coefficient of friction of the first coating material is greater than 0.2, greater than 0.3, greater than 0.4, greater than 0.5.
In one embodiment the coefficient of friction of the second coating material is less than 0.2, less than 0.15, less than 0.1, less than 0.08.
Another embodiment of a device of this invention comprises a clot retrieval device comprising an elongate shaft and an expandable member, the expandable member comprising a proximal section, a body section and a distal section, the body section comprising a metallic framework of a first (or substrate) material, the metallic framework comprising a plurality of strut elements, said strut elements comprising an outer surface, an inner surface and side wall surfaces, at least one of said surfaces comprising a smooth surface and recessed features, at least some of said recessed features at least partially filled with a second (coating) material.
In one embodiment the recessed features comprise grooves or slots in the top surface of a strut element.
In one case the recessed features comprise holes in the top surface of a strut element.
In one embodiment the recessed features comprise holes through a strut element.
In one case the above holes are circular, or oblong, or square or rectangular.
In one embodiment the recessed features comprise grooves or slots in the side wall of a strut element.
In one case all of the recessed features are filled with the second (coating) material.
In one embodiment at least one of the smooth surfaces are coated with the second (coating) material.
In one case all of the smooth surfaces are coated with the second (coating) material.
In one embodiment the thickness of coating material in the recessed features is greater than the thickness of coating material on the smooth surfaces.
Another aspect of this invention comprises a method of manufacturing the expandable body of a clot retrieval device, the expandable body comprising a substrate material and a coating material, the method comprising: a first step of removing material from discrete areas of the substrate material to form recesses, a second step of applying the coating material to the substrate material and recesses, and a third step of removing some or all of the coating from the non-recessed areas of the substrate.
Another aspect of this invention comprises a method of applying a radiopaque coating to selective areas of the expandable body of a clot retrieval device, the method involving a masking material and comprising:
Another aspect of this invention comprises a method of manufacturing the expandable body of a clot retrieval device, the expandable body comprising a substrate material and a coating material, the method involving a masking material and comprising:
In one embodiment the fourth step comprises an electroplating process, a dipping process, a plasma deposition process, an electrostatic process, a dip or spray coating process, a sputtering process, a soldering process, a cladding process or a drawing process.
In one case the second step comprises a grinding process, a polishing process, a buffing process, an etching process, a laser cutting or laser ablation process.
In one case the third step comprises a laser cutting process, a wire cutting process, a water jet cutting process, a machining process or an etching process.
In one embodiment the coating material is Gold, Tantalum, Tungsten, Platinum or an alloy of one of these elements or other dense element or alloy containing one or more radiodense elements.
In one case the coating material comprises a polymer or adhesive filled with a dense or high atomic number material such as Barium Sulphate, Bismuth SubCarbonate, Barium OxyChloride, Gold, Tungsten, Platinum or Tantalum.
In one embodiment the substrate material comprises Nitinol, or an alloy of Nitinol or another super or pseudo elastic alloy.
In one case the expandable body comprises a plurality of strut elements and connector elements.
In one embodiment the expandable body of the Clot Retrieval device comprises an expanded state and a collapsed state.
In one case the third step results in the masking material being positioned on those areas of the expandable body which experience the highest strain in moving from the expanded state to the collapsed state, and/or from the collapsed state to the expanded state.
Another embodiment of a device of this invention comprises a clot retrieval device comprising an expandable body and an elongate shaft, the expandable body comprising a proximal section, a body section and a distal section, the body section comprising a framework of strut elements and at least one fibre assembly, the fibre assembly comprising a radiodense material.
In one embodiment the distal section comprises a clot capture scaffold.
In one case the clot capture scaffold comprises a net.
In one embodiment the fibre assembly comprises at least one fibre and at least one floating element, the floating element comprising a radiodense material.
In one case the fibre comprises a polymer monofilament, or plurality of polymer filaments.
In one embodiment the polymer filament is of LCP, Aramid, PEN, PET, or UHMWPE.
In one case the fibre comprises at least one metallic filament.
In one embodiment the metallic filament is a nitinol wire, or plurality of such wires.
In one case the metallic filament comprises a nitinol outer layer with an inner core of a radiodense material such as Gold, Platinum, Tantalum or Tungsten.
In one embodiment the floating element is a coil, a tube, or a bead.
In one case the material of the floating element comprises Gold, Tantalum, Tungsten, Platinum or an alloy of one of these elements or other dense element or alloy containing one or more radiodense elements.
In one embodiment the material of the floating element comprises a polymer filled with a dense and/or high atomic number material such as Barium Sulphate, Bismuth SubCarbonate, Barium OxyChloride or Tantalum.
Specific embodiments of the present invention are now described in detail with reference to the Figures, wherein identical reference numbers indicate identical or functionality similar elements. The terms “distal” or “proximal” are used in the following description with respect to a position or direction relative to the treating physician. “Distal” or “distally” are a position distant from or in a direction away from the physician. “Proximal” or “proximally” or “proximate” are a position near or in a direction toward the physician.
The following detailed description is merely exemplary in nature and is not intended to limit the invention or the application and uses of the invention. Although the description of the invention is in the context of treatment of intracranial arteries, the invention may also be used in other body passageways as previously described.
Positional visualization of this device may be provided by a proximal radiopaque coil 109 and distal radiopaque markers 108. User visualization of device 100 would be enhanced by providing visual information to the user on device expansion in a vessel or clot. This information may allow the user to visualise the profile of a clot and provide a fuller map of the luminal space created upon device deployment. As the device is withdrawn, the user will see the device response as it tracks through the anatomy with clot incorporated. It is therefore desirable to add radiopaque materials to outer member 102 and/or to inner tubular member 101 to provide the highest quality information to the user. One of the challenges with incorporating radiopaque material in such a manner is the dampening effect such materials have on superelastic Nitinol. The inventions disclosed in this document facilitate incorporation of radiopaque material and therefore product visualization without compromising the superelastic response of the outer member or inner tubular member. It is intended that any of the designs and inventions disclosed may be adopted to enhance the radiopacity of a clot retrieval device such as shown in
In the embodiment shown the radiopacity of the outer member is enhanced by the presence of radiopaque elements 107, which are attached to the outer member by supporting fibres 106. These fibres may be connected to the framework of the outer member by a variety of means, including threading the fibres through eyelets or attachment features. Radiopaque elements 107 may comprise tubes, beads or coils of a radiodense material such as Gold, Tungsten, Tantalum, Platinum or alloy containing these or other high atomic number elements. Polymer materials might also be employed, containing a radiopaque filler such as Barium Sulphate, Bismuth SubCarbonate, Barium OxyChloride or Tantalum.
A particular advantage of this design is that effective radiopacity may be achieved through the addition of a much lower volume of radiopaque material than would otherwise be possible. For example, if an endovascular medical device comprised a Nitinol strut of width and thickness of between 50 and 100 microns approximately, such a strut would typically be very difficult for a physician to see under fluoroscopy. If portions of such a strut were made wider as per sections 2104 of
The widened portion of the strut may be at least 50%, optionally at least 75%, optionally at least 100%, optionally at least 125%, optionally at least 150%, optionally at least 175%, optionally at least 200%, optionally at least 300% wider than the regions along the length of the strut between the widened portions.
The widened portions may have a length which is less than 100%, optionally less than 75%, optionally less than 50%, optionally less than 25% of the length of the regions of the strut between the widened portions.
The length of the regions of the strut between the widened portions may be greater than 300%, optionally greater than 400%, optionally greater than 500%, optionally greater than 600%, optionally greater than 700%, optionally greater than 800%, optionally greater than 900% of the width of the strut.
Deformation, such as the applied bending load shown in
Referring now to
In the embodiment shown the sidewalls 3307 of struts 3302 and crown features 3303 are profiled with a corrugated shape 3305. This corrugated shape serves to increase the surface area of the device and helps to reduce the damping effect of the radiopaque coating on the recovery of the Nitinol device. When device 3301 is wrapped down for delivery, the struts and crowns deform and bend. As the struts bend the side walls either elongate or compress depending on whether they are in tension or compression. The strain induced by this elongation or compression can cause plastic deformation in the radiopaque coating if it is greater than the elastic strain limit of the material, which is typically less than 1%. However the corrugated surface has the effect of increasing the effective length of the side wall of the strut and thus reducing the effective strain on the radiopaque coating, so that the damping effect can be reduced or eliminated.
Modification and additions can be made to the embodiments of the invention described herein without departing from the scope of the invention. For example, while the embodiments described herein refer to particular features, the invention includes embodiments having different combinations of features. The invention also includes embodiments that do not include all of the specific features described.
The invention is not limited to the embodiments hereinbefore described which may be varied in construction and detail.
This application is a U.S. national phase entry under 35 U.S.C. § 371 of International PCT Application No. PCT/EP2014/054828, filed on Mar. 12, 2014, which claims priority to U.S. Provisional Application No. 61/784,940, filed on Mar. 14, 2013.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2014/054828 | 3/12/2014 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2014/140092 | 9/18/2014 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4793348 | Palmaz | Dec 1988 | A |
4873978 | Ginsburg | Oct 1989 | A |
5011488 | Ginsburg | Apr 1991 | A |
5092839 | Kipperman | Mar 1992 | A |
5122136 | Guglielmi et al. | Jun 1992 | A |
5171233 | Amplatz | Dec 1992 | A |
5234437 | Sepetka | Aug 1993 | A |
5387219 | Rappe | Feb 1995 | A |
5387226 | Miraki | Feb 1995 | A |
5449372 | Schmaltz | Sep 1995 | A |
5538512 | Zenzon et al. | Jul 1996 | A |
5549626 | Miller et al. | Aug 1996 | A |
5558652 | Henke | Sep 1996 | A |
5609627 | Goicoechea et al. | Mar 1997 | A |
5624461 | Mariant | Apr 1997 | A |
5639277 | Mariant | Jun 1997 | A |
5645558 | Horton | Jul 1997 | A |
5658296 | Bates | Aug 1997 | A |
5695519 | Summers et al. | Dec 1997 | A |
5709704 | Nott et al. | Jan 1998 | A |
5713853 | Clark | Feb 1998 | A |
5769871 | Mers Kelly | Jun 1998 | A |
5779716 | Cano | Jul 1998 | A |
5810874 | Lefebvre | Sep 1998 | A |
5814064 | Daniel et al. | Sep 1998 | A |
5827304 | Hart | Oct 1998 | A |
5855598 | Pinchuk | Jan 1999 | A |
5893869 | Barnhart et al. | Apr 1999 | A |
5895398 | Wensel | Apr 1999 | A |
5897567 | Ressemann | Apr 1999 | A |
5904698 | Thomas et al. | May 1999 | A |
5911725 | Boury | Jun 1999 | A |
5935139 | Bates | Aug 1999 | A |
5947995 | Samuels | Sep 1999 | A |
6063113 | Kavteladze et al. | May 2000 | A |
6066149 | Samson et al. | May 2000 | A |
6066158 | Engelson | May 2000 | A |
6093196 | Okada | Jul 2000 | A |
6093199 | Brown et al. | Jul 2000 | A |
6096053 | Bates | Aug 2000 | A |
6099534 | Bates | Aug 2000 | A |
6102932 | Kurz | Aug 2000 | A |
6106548 | Roubin et al. | Aug 2000 | A |
6129739 | Khosravi | Oct 2000 | A |
6146404 | Kim | Nov 2000 | A |
6165194 | Denardo | Dec 2000 | A |
6165199 | Barbut | Dec 2000 | A |
6168604 | Cano | Jan 2001 | B1 |
6174318 | Bates et al. | Jan 2001 | B1 |
6179861 | Khosravi | Jan 2001 | B1 |
6203561 | Ramee | Mar 2001 | B1 |
6214026 | Lepak | Apr 2001 | B1 |
6221006 | Dubrul | Apr 2001 | B1 |
6238412 | Dubrul | May 2001 | B1 |
6245087 | Addis | Jun 2001 | B1 |
6251122 | Tsukernik | Jun 2001 | B1 |
6254571 | Hart | Jul 2001 | B1 |
6264663 | Cano | Jul 2001 | B1 |
6312444 | Barbut | Nov 2001 | B1 |
6325819 | Pavenik et al. | Dec 2001 | B1 |
6336934 | Gilson et al. | Jan 2002 | B1 |
6348056 | Bates | Feb 2002 | B1 |
6350271 | Kurz et al. | Feb 2002 | B1 |
6361545 | Macoviak et al. | Mar 2002 | B1 |
6364895 | Greenhalgh | Apr 2002 | B1 |
6383205 | Samson et al. | May 2002 | B1 |
6383206 | Gillick | May 2002 | B1 |
6402771 | Palmer | Jun 2002 | B1 |
6416541 | Denardo | Jul 2002 | B2 |
6425909 | Dieck et al. | Jul 2002 | B1 |
6432122 | Gilson et al. | Aug 2002 | B1 |
6436112 | Wensel | Aug 2002 | B2 |
6458139 | Palmer | Oct 2002 | B1 |
6485497 | Wensel | Nov 2002 | B2 |
6485501 | Green | Nov 2002 | B1 |
6485502 | Don Michael | Nov 2002 | B2 |
6511492 | Rosenbluth | Jan 2003 | B1 |
6530935 | Wensel | Mar 2003 | B2 |
6530939 | Hopkins | Mar 2003 | B1 |
6540768 | Diaz et al. | Apr 2003 | B1 |
6544279 | Hopkins | Apr 2003 | B1 |
6551341 | Boylan et al. | Apr 2003 | B2 |
6551342 | Shen et al. | Apr 2003 | B1 |
6575997 | Palmer et al. | Jun 2003 | B1 |
6582448 | Boyle | Jun 2003 | B1 |
6585756 | Strecker | Jul 2003 | B1 |
6589265 | Palmer et al. | Jul 2003 | B1 |
6592607 | Palmer et al. | Jul 2003 | B1 |
6592616 | Stack | Jul 2003 | B1 |
6602271 | Adams | Aug 2003 | B2 |
6602272 | Boylan et al. | Aug 2003 | B2 |
6610077 | Hancock et al. | Aug 2003 | B1 |
6616679 | Khosravi | Sep 2003 | B1 |
6632241 | Hancock et al. | Oct 2003 | B1 |
6638245 | Miller | Oct 2003 | B2 |
6638293 | Makower et al. | Oct 2003 | B1 |
6641590 | Palmer et al. | Nov 2003 | B1 |
6656218 | Denardo et al. | Dec 2003 | B1 |
6660021 | Palmer et al. | Dec 2003 | B1 |
6663650 | Sepetka | Dec 2003 | B2 |
6673089 | Yassour et al. | Jan 2004 | B1 |
6685722 | Rosenbluth | Feb 2004 | B1 |
6692504 | Kurz et al. | Feb 2004 | B2 |
6692508 | Wensel | Feb 2004 | B2 |
6692509 | Wensel | Feb 2004 | B2 |
6702782 | Miller | Mar 2004 | B2 |
6712834 | Yassour et al. | Mar 2004 | B2 |
6726701 | Gilson et al. | Apr 2004 | B2 |
6730104 | Sepetka | May 2004 | B1 |
6824545 | Sepetka | Nov 2004 | B2 |
6855155 | Denardo et al. | Feb 2005 | B2 |
6878163 | Denardo et al. | Apr 2005 | B2 |
6890340 | Duane | May 2005 | B2 |
6913612 | Palmer | Jul 2005 | B2 |
6913618 | Denardo et al. | Jul 2005 | B2 |
6953472 | Palmer et al. | Oct 2005 | B2 |
6989019 | Mazzocchi | Jan 2006 | B2 |
6989021 | Bosma et al. | Jan 2006 | B2 |
6994718 | Groothuis et al. | Feb 2006 | B2 |
7004954 | Voss et al. | Feb 2006 | B1 |
7004955 | Shen | Feb 2006 | B2 |
7004956 | Palmer | Feb 2006 | B2 |
7008434 | Kurz et al. | Mar 2006 | B2 |
7033376 | Tsukernik | Apr 2006 | B2 |
7041116 | Goto | May 2006 | B2 |
7048758 | Boyle | May 2006 | B2 |
7058456 | Pierce | Jun 2006 | B2 |
7063707 | Bose | Jun 2006 | B2 |
7175655 | Malaei | Feb 2007 | B1 |
7179273 | Palmer et al. | Feb 2007 | B1 |
7220271 | Clubb | May 2007 | B2 |
7229472 | DePalma et al. | Jun 2007 | B2 |
7288112 | Denardo et al. | Oct 2007 | B2 |
7306618 | Demond | Dec 2007 | B2 |
7316692 | Huffmaster | Jan 2008 | B2 |
7323001 | Clubb | Jan 2008 | B2 |
7331976 | McGuckin, Jr. et al. | Feb 2008 | B2 |
7344550 | Carrison et al. | Mar 2008 | B2 |
7399308 | Borillo et al. | Jul 2008 | B2 |
7410491 | Hopkins | Aug 2008 | B2 |
7452496 | Brady et al. | Nov 2008 | B2 |
7491215 | Vale et al. | Feb 2009 | B2 |
7491216 | Brady | Feb 2009 | B2 |
7510565 | Gilson et al. | Mar 2009 | B2 |
7534252 | Sepetka | May 2009 | B2 |
7556636 | Mazzocchi | Jul 2009 | B2 |
7582111 | Krolik et al. | Sep 2009 | B2 |
7594926 | Linder | Sep 2009 | B2 |
7604649 | McGuckin, Jr. et al. | Oct 2009 | B2 |
7618434 | Santra | Nov 2009 | B2 |
7662165 | Gilson et al. | Feb 2010 | B2 |
7670356 | Mazzocchi | Mar 2010 | B2 |
7691121 | Rosenbluth | Apr 2010 | B2 |
7691124 | Balgobin | Apr 2010 | B2 |
7708770 | Linder | May 2010 | B2 |
7736385 | Agnew | Jun 2010 | B2 |
7766934 | Pal | Aug 2010 | B2 |
7771452 | Pal | Aug 2010 | B2 |
7780694 | Palmer | Aug 2010 | B2 |
7828815 | Mazzocchi | Nov 2010 | B2 |
7846176 | Mazzocchi | Nov 2010 | B2 |
7846175 | Bonnette et al. | Dec 2010 | B2 |
7850708 | Pal | Dec 2010 | B2 |
7887560 | Kusleika | Feb 2011 | B2 |
7901426 | Gilson et al. | Mar 2011 | B2 |
7914549 | Morsi | Mar 2011 | B2 |
7922732 | Mazzocchi | Apr 2011 | B2 |
7927784 | Simpson | Apr 2011 | B2 |
7931659 | Bose et al. | Apr 2011 | B2 |
7998165 | Huffmaster | Aug 2011 | B2 |
8002822 | Glocker et al. | Aug 2011 | B2 |
8021379 | Thompson et al. | Sep 2011 | B2 |
8021380 | Thompson et al. | Sep 2011 | B2 |
8043326 | Hancock et al. | Oct 2011 | B2 |
8048151 | O'Brien et al. | Nov 2011 | B2 |
8052640 | Fiorella et al. | Nov 2011 | B2 |
8057497 | Raju et al. | Nov 2011 | B1 |
8066757 | Ferrera et al. | Nov 2011 | B2 |
8070791 | Ferrera et al. | Dec 2011 | B2 |
8088140 | Ferrera et al. | Jan 2012 | B2 |
8100935 | Rosenbluth et al. | Jan 2012 | B2 |
8109941 | Richardson | Feb 2012 | B2 |
8118829 | Carrison et al. | Feb 2012 | B2 |
8123769 | Osborne | Feb 2012 | B2 |
8137377 | Palmer et al. | Mar 2012 | B2 |
8142422 | Makower et al. | Mar 2012 | B2 |
8142442 | Palmer et al. | Mar 2012 | B2 |
8182508 | Magnuson et al. | May 2012 | B2 |
8187298 | Pal | May 2012 | B2 |
8246641 | Osborne et al. | Aug 2012 | B2 |
8246672 | Osborne et al. | Aug 2012 | B2 |
8252017 | Paul, Jr. et al. | Aug 2012 | B2 |
8252018 | Valaie | Aug 2012 | B2 |
8357178 | Grandfield et al. | Jan 2013 | B2 |
8357179 | Grandfield et al. | Jan 2013 | B2 |
8361095 | Osborne | Jan 2013 | B2 |
8366663 | Fiorella et al. | Feb 2013 | B2 |
8409215 | Sepetka et al. | Apr 2013 | B2 |
8419748 | Valaie | Apr 2013 | B2 |
8460312 | Bose et al. | Jun 2013 | B2 |
8460313 | Huffmaster | Jun 2013 | B2 |
8486104 | Samson et al. | Jul 2013 | B2 |
8529596 | Grandfield et al. | Sep 2013 | B2 |
8574262 | Ferrera et al. | Nov 2013 | B2 |
8579915 | French et al. | Nov 2013 | B2 |
8585713 | Ferrera et al. | Nov 2013 | B2 |
8608761 | Osborne et al. | Dec 2013 | B2 |
8679142 | Slee et al. | Mar 2014 | B2 |
8696622 | Fiorella et al. | Apr 2014 | B2 |
8702652 | Fiorella et al. | Apr 2014 | B2 |
8702724 | Olsen et al. | Apr 2014 | B2 |
8784434 | Rosenbluth et al. | Jul 2014 | B2 |
8784441 | Rosenbluth et al. | Jul 2014 | B2 |
8795305 | Martin et al. | Aug 2014 | B2 |
8795317 | Grandfield et al. | Aug 2014 | B2 |
8795345 | Grandfield et al. | Aug 2014 | B2 |
8814925 | Hilaire et al. | Aug 2014 | B2 |
8900265 | Ulm, III | Dec 2014 | B1 |
8939991 | Krolik et al. | Jan 2015 | B2 |
8945143 | Ferrera et al. | Feb 2015 | B2 |
8945172 | Ferrera et al. | Feb 2015 | B2 |
8968330 | Rosenbluth et al. | Mar 2015 | B2 |
9039749 | Shrivastava et al. | May 2015 | B2 |
9072537 | Grandfield et al. | Jul 2015 | B2 |
9113936 | Palmer et al. | Aug 2015 | B2 |
9119656 | Bose et al. | Sep 2015 | B2 |
9138307 | Valaie | Sep 2015 | B2 |
9155552 | Ulm, III | Oct 2015 | B2 |
9161766 | Slee et al. | Oct 2015 | B2 |
9173668 | Ulm, III | Nov 2015 | B2 |
9186487 | Dubrul et al. | Nov 2015 | B2 |
9198687 | Fulkerson et al. | Dec 2015 | B2 |
9204887 | Cully et al. | Dec 2015 | B2 |
9211132 | Bowman | Dec 2015 | B2 |
9532792 | Galdonik et al. | Jan 2017 | B2 |
9532873 | Kelley | Jan 2017 | B2 |
9533344 | Monetti et al. | Jan 2017 | B2 |
9539011 | Chen et al. | Jan 2017 | B2 |
9539022 | Bowman | Jan 2017 | B2 |
9539122 | Burke et al. | Jan 2017 | B2 |
9539382 | Nelson | Jan 2017 | B2 |
9549830 | Bruszewski et al. | Jan 2017 | B2 |
9554805 | Tompkins et al. | Jan 2017 | B2 |
9561125 | Bowman et al. | Feb 2017 | B2 |
9572982 | Burnes et al. | Feb 2017 | B2 |
9579484 | Barnell | Feb 2017 | B2 |
9585642 | Dinsmoor et al. | Mar 2017 | B2 |
9615832 | Bose et al. | Apr 2017 | B2 |
9615951 | Bennett et al. | Apr 2017 | B2 |
9622753 | Cox | Apr 2017 | B2 |
9636115 | Henry et al. | May 2017 | B2 |
9636439 | Chu et al. | May 2017 | B2 |
9642675 | Werneth et al. | May 2017 | B2 |
9655633 | Leynov et al. | May 2017 | B2 |
9655645 | Staunton | May 2017 | B2 |
9655989 | Cruise et al. | May 2017 | B2 |
9662129 | Galdonik et al. | May 2017 | B2 |
9662238 | Dwork et al. | May 2017 | B2 |
9662425 | Lilja et al. | May 2017 | B2 |
9668898 | Wong | Jun 2017 | B2 |
9675477 | Thompson | Jun 2017 | B2 |
9675782 | Connolly | Jun 2017 | B2 |
9676022 | Ensign | Jun 2017 | B2 |
9692557 | Murphy | Jun 2017 | B2 |
9693852 | Lam et al. | Jul 2017 | B2 |
9700262 | Janik et al. | Jul 2017 | B2 |
9700399 | Acosta-Acevedo | Jul 2017 | B2 |
9717421 | Griswold et al. | Aug 2017 | B2 |
9717500 | Tieu et al. | Aug 2017 | B2 |
9717502 | Teoh et al. | Aug 2017 | B2 |
9724103 | Cruise et al. | Aug 2017 | B2 |
9724526 | Strother et al. | Aug 2017 | B2 |
9750565 | Bloom et al. | Sep 2017 | B2 |
9757260 | Greenan | Sep 2017 | B2 |
9764111 | Gulachenski | Sep 2017 | B2 |
9770251 | Bowman | Sep 2017 | B2 |
9770577 | Li | Sep 2017 | B2 |
9775621 | Tompkins et al. | Oct 2017 | B2 |
9775706 | Peterson | Oct 2017 | B2 |
9775732 | Khenansho | Oct 2017 | B2 |
9788800 | Mayoras, Jr. | Oct 2017 | B2 |
9795391 | Saatchi et al. | Oct 2017 | B2 |
9801980 | Karino et al. | Oct 2017 | B2 |
9808599 | Bowman | Nov 2017 | B2 |
9833252 | Sepetka | Dec 2017 | B2 |
9833604 | Lam | Dec 2017 | B2 |
9833625 | Waldhauser et al. | Dec 2017 | B2 |
20010001315 | Bates | May 2001 | A1 |
20010016755 | Addis | Aug 2001 | A1 |
20010051810 | Dubrul | Dec 2001 | A1 |
20020016609 | Wensel | Feb 2002 | A1 |
20020022859 | Hogendijk | Feb 2002 | A1 |
20020026211 | Khosravi | Feb 2002 | A1 |
20020049468 | Streeter et al. | Apr 2002 | A1 |
20020052620 | Barbut | May 2002 | A1 |
20020068954 | Foster | Jun 2002 | A1 |
20020072764 | Sepetka | Jun 2002 | A1 |
20020082558 | Samson | Jun 2002 | A1 |
20020091407 | Zadno-Azizi et al. | Jul 2002 | A1 |
20020095171 | Belef | Jul 2002 | A1 |
20020123765 | Sepetka | Sep 2002 | A1 |
20020143362 | Macoviak et al. | Oct 2002 | A1 |
20020156455 | Barbut | Oct 2002 | A1 |
20020161393 | Demond | Oct 2002 | A1 |
20020165576 | Boyle et al. | Nov 2002 | A1 |
20020173819 | Leeflang et al. | Nov 2002 | A1 |
20020188276 | Evans | Dec 2002 | A1 |
20030004536 | Boylan et al. | Jan 2003 | A1 |
20030004538 | Secrest | Jan 2003 | A1 |
20030004542 | Wensel | Jan 2003 | A1 |
20030009146 | Muni | Jan 2003 | A1 |
20030009191 | Wensel | Jan 2003 | A1 |
20030040772 | Hyodoh et al. | Feb 2003 | A1 |
20030050663 | Khachin | Mar 2003 | A1 |
20030125798 | Martin | Jul 2003 | A1 |
20030144687 | Brady et al. | Jul 2003 | A1 |
20030153943 | Michael et al. | Aug 2003 | A1 |
20030153944 | Phung | Aug 2003 | A1 |
20030163064 | Vrba | Aug 2003 | A1 |
20030163158 | White | Aug 2003 | A1 |
20030171769 | Barbut | Sep 2003 | A1 |
20030176884 | Berrada et al. | Sep 2003 | A1 |
20030195537 | Dubrul | Oct 2003 | A1 |
20030195554 | Shen | Oct 2003 | A1 |
20030199917 | Knudson | Oct 2003 | A1 |
20030204202 | Palmer | Oct 2003 | A1 |
20030212430 | Bose | Nov 2003 | A1 |
20030236533 | Wilson | Dec 2003 | A1 |
20040068288 | Palmer et al. | Apr 2004 | A1 |
20040073243 | Sepetka | Apr 2004 | A1 |
20040079429 | Miller | Apr 2004 | A1 |
20040082962 | Demarais et al. | Apr 2004 | A1 |
20040093065 | Yachia et al. | May 2004 | A1 |
20040133231 | Maitland | Jul 2004 | A1 |
20040138692 | Phung | Jul 2004 | A1 |
20040153118 | Clubb | Aug 2004 | A1 |
20050033348 | Sepetka | Feb 2005 | A1 |
20050038447 | Huffmaster | Feb 2005 | A1 |
20050038468 | Panetta et al. | Feb 2005 | A1 |
20050049619 | Sepetka | Mar 2005 | A1 |
20050049669 | Jones | Mar 2005 | A1 |
20050049670 | Jones et al. | Mar 2005 | A1 |
20050055033 | Leslie et al. | Mar 2005 | A1 |
20050055047 | Greenhalgh | Mar 2005 | A1 |
20050059995 | Sepetka | Mar 2005 | A1 |
20050085849 | Sepetka | Apr 2005 | A1 |
20050090857 | Kusleika et al. | Apr 2005 | A1 |
20050125024 | Sepetka | Jun 2005 | A1 |
20050171566 | Kanamaru | Aug 2005 | A1 |
20050216030 | Sepetka | Sep 2005 | A1 |
20050216050 | Sepetka | Sep 2005 | A1 |
20050228417 | Teitelbaum et al. | Oct 2005 | A1 |
20050267491 | Kellett et al. | Dec 2005 | A1 |
20050288686 | Sepetka | Dec 2005 | A1 |
20060009799 | Kleshinski et al. | Jan 2006 | A1 |
20060058836 | Bose | Mar 2006 | A1 |
20060058837 | Bose | Mar 2006 | A1 |
20060058838 | Bose | Mar 2006 | A1 |
20060064151 | Guterman et al. | Mar 2006 | A1 |
20060149313 | Arguello et al. | Jul 2006 | A1 |
20060155305 | Freudenthal | Jul 2006 | A1 |
20060161187 | Levine et al. | Jul 2006 | A1 |
20060195137 | Sepetka | Aug 2006 | A1 |
20060224177 | Finitsis | Oct 2006 | A1 |
20060224179 | Kucharczyk | Oct 2006 | A1 |
20060229638 | Abrams et al. | Oct 2006 | A1 |
20060282111 | Morsi | Dec 2006 | A1 |
20060287701 | Pal | Dec 2006 | A1 |
20070088383 | Pal et al. | Apr 2007 | A1 |
20070156170 | Hancock | Jul 2007 | A1 |
20070165170 | Fukuda | Jul 2007 | A1 |
20070191866 | Palmer et al. | Aug 2007 | A1 |
20070198028 | Miloslavski | Aug 2007 | A1 |
20070198051 | Clubb et al. | Aug 2007 | A1 |
20070198075 | Levy | Aug 2007 | A1 |
20070208367 | Fiorella | Sep 2007 | A1 |
20070208371 | French | Sep 2007 | A1 |
20070225749 | Martin | Sep 2007 | A1 |
20070244505 | Gilson et al. | Oct 2007 | A1 |
20070270902 | Slazas et al. | Nov 2007 | A1 |
20080045881 | Teitelbaum et al. | Feb 2008 | A1 |
20080082107 | Miller et al. | Apr 2008 | A1 |
20080086190 | Ta | Apr 2008 | A1 |
20080091223 | Pokorney | Apr 2008 | A1 |
20080109031 | Sepetka | May 2008 | A1 |
20080109032 | Sepetka | May 2008 | A1 |
20080119886 | Greenhalgh et al. | May 2008 | A1 |
20080177296 | Sepetka | Jul 2008 | A1 |
20080183197 | Sepetka | Jul 2008 | A1 |
20080183198 | Sepetka | Jul 2008 | A1 |
20080183205 | Sepetka | Jul 2008 | A1 |
20080188876 | Sepetka | Aug 2008 | A1 |
20080188885 | Sepetka | Aug 2008 | A1 |
20080200946 | Braun | Aug 2008 | A1 |
20080215077 | Sepetka | Sep 2008 | A1 |
20080221600 | Dieck et al. | Sep 2008 | A1 |
20080228209 | DeMello et al. | Sep 2008 | A1 |
20080234706 | Sepetka | Sep 2008 | A1 |
20080243170 | Jenson | Oct 2008 | A1 |
20080255596 | Jenson | Oct 2008 | A1 |
20080262528 | Martin | Oct 2008 | A1 |
20080262532 | Martin | Oct 2008 | A1 |
20080275488 | Fleming | Nov 2008 | A1 |
20080275493 | Farmiga | Nov 2008 | A1 |
20080312681 | Ansel | Dec 2008 | A1 |
20090024157 | Anukhin | Jan 2009 | A1 |
20090069828 | Martin | Mar 2009 | A1 |
20090076539 | Valaie | Mar 2009 | A1 |
20090105722 | Fulkerson | Apr 2009 | A1 |
20090105737 | Fulkerson | Apr 2009 | A1 |
20090281610 | Parker | Nov 2009 | A1 |
20090292297 | Ferrere | Nov 2009 | A1 |
20090292307 | Razack | Nov 2009 | A1 |
20090299393 | Martin | Dec 2009 | A1 |
20090306702 | Miloslavski | Dec 2009 | A1 |
20100004607 | Wilson et al. | Jan 2010 | A1 |
20100087908 | Hilaire | Apr 2010 | A1 |
20100114017 | Lenker | May 2010 | A1 |
20100125326 | Kalstad | May 2010 | A1 |
20100125327 | Agnew | May 2010 | A1 |
20100191272 | Keating | Jul 2010 | A1 |
20100211094 | Sargent, Jr. | Aug 2010 | A1 |
20100268264 | Bonnett et al. | Oct 2010 | A1 |
20100268265 | Krolik et al. | Oct 2010 | A1 |
20100318178 | Rapaport et al. | Dec 2010 | A1 |
20100331949 | Habib | Dec 2010 | A1 |
20110009875 | Grandfield et al. | Jan 2011 | A1 |
20110009940 | Grandfield et al. | Jan 2011 | A1 |
20110022149 | Cox et al. | Jan 2011 | A1 |
20110054514 | Arcand | Mar 2011 | A1 |
20110054516 | Keegan | Mar 2011 | A1 |
20110060359 | Hannes | Mar 2011 | A1 |
20110054504 | Wolf et al. | May 2011 | A1 |
20110125181 | Brady et al. | May 2011 | A1 |
20110152920 | Eckhouse et al. | Jun 2011 | A1 |
20110160763 | Ferrera et al. | Jun 2011 | A1 |
20110166586 | Sepetka et al. | Jul 2011 | A1 |
20110196414 | Porter et al. | Aug 2011 | A1 |
20110202088 | Eckhouse et al. | Aug 2011 | A1 |
20110213403 | Aboytes | Sep 2011 | A1 |
20110224707 | Miloslavaski et al. | Sep 2011 | A1 |
20110276120 | Gilson et al. | Nov 2011 | A1 |
20120041449 | Eckhouse et al. | Feb 2012 | A1 |
20120041474 | Eckhouse et al. | Feb 2012 | A1 |
20120059356 | di Palma et al. | Mar 2012 | A1 |
20120089216 | Rapaport et al. | Apr 2012 | A1 |
20120143237 | Cam et al. | Jun 2012 | A1 |
20120150147 | Leynov et al. | Jun 2012 | A1 |
20120165858 | Eckhouse et al. | Jun 2012 | A1 |
20120165859 | Eckhouse et al. | Jun 2012 | A1 |
20120277788 | Cattaneo | Nov 2012 | A1 |
20120296362 | Cam et al. | Nov 2012 | A1 |
20130030461 | Marks et al. | Jan 2013 | A1 |
20130046330 | McIntosh et al. | Feb 2013 | A1 |
20130046333 | Jones et al. | Feb 2013 | A1 |
20130046334 | Jones et al. | Feb 2013 | A1 |
20130116774 | Strauss et al. | May 2013 | A1 |
20130144326 | Brady et al. | Jun 2013 | A1 |
20130158592 | Porter | Jun 2013 | A1 |
20130184739 | Brady et al. | Jul 2013 | A1 |
20130197567 | Brady et al. | Aug 2013 | A1 |
20130226146 | Tekulve | Aug 2013 | A1 |
20130268050 | Wilson et al. | Oct 2013 | A1 |
20130281788 | Garrison | Oct 2013 | A1 |
20130325055 | Eckhouse et al. | Dec 2013 | A1 |
20130325056 | Eckhouse et al. | Dec 2013 | A1 |
20130345739 | Brady et al. | Dec 2013 | A1 |
20140046359 | Bowman et al. | Feb 2014 | A1 |
20140121672 | Folk | May 2014 | A1 |
20140128905 | Molaei | May 2014 | A1 |
20140180377 | Bose et al. | Jun 2014 | A1 |
20140194919 | Losordo et al. | Jul 2014 | A1 |
20140200608 | Brady et al. | Jul 2014 | A1 |
20140236220 | Inoue | Aug 2014 | A1 |
20140257362 | Eidenschink | Sep 2014 | A1 |
20140276922 | McLain et al. | Sep 2014 | A1 |
20140277079 | Vale et al. | Sep 2014 | A1 |
20140309657 | Ben-Ami | Oct 2014 | A1 |
20140309673 | Dacuycuy et al. | Oct 2014 | A1 |
20140330302 | Tekulve et al. | Nov 2014 | A1 |
20140343585 | Ferrera et al. | Nov 2014 | A1 |
20140371769 | Vale et al. | Dec 2014 | A1 |
20140371779 | Vale et al. | Dec 2014 | A1 |
20140371780 | Vale et al. | Dec 2014 | A1 |
20140372779 | Wong et al. | Dec 2014 | A1 |
20140379023 | Brady et al. | Dec 2014 | A1 |
20150018859 | Quick et al. | Jan 2015 | A1 |
20150018860 | Quick et al. | Jan 2015 | A1 |
20150080937 | Davidson | Mar 2015 | A1 |
20150112376 | Molaei et al. | Apr 2015 | A1 |
20150133990 | Davidson | May 2015 | A1 |
20150164523 | Brady et al. | Jun 2015 | A1 |
20150250497 | Marks et al. | Sep 2015 | A1 |
20150257775 | Gilvarry et al. | Sep 2015 | A1 |
20150297252 | Miloslayski et al. | Oct 2015 | A1 |
20150313617 | Grandfield et al. | Nov 2015 | A1 |
20150320431 | Ulm, III | Nov 2015 | A1 |
20150352325 | Quick | Dec 2015 | A1 |
20150359547 | Vale et al. | Dec 2015 | A1 |
20150374391 | Quick et al. | Dec 2015 | A1 |
20150374393 | Brady et al. | Dec 2015 | A1 |
20150374479 | Vale | Dec 2015 | A1 |
20160015402 | Brady et al. | Jan 2016 | A1 |
20160022296 | Brady et al. | Jan 2016 | A1 |
20160066921 | Seifert et al. | Mar 2016 | A1 |
20160106448 | Brady et al. | Apr 2016 | A1 |
20160106449 | Brady et al. | Apr 2016 | A1 |
20160113663 | Brady et al. | Apr 2016 | A1 |
20160113664 | Brady et al. | Apr 2016 | A1 |
20160113665 | Brady et al. | Apr 2016 | A1 |
20160120558 | Brady et al. | May 2016 | A1 |
20160143653 | Vale et al. | May 2016 | A1 |
20160192953 | Brady et al. | Jul 2016 | A1 |
20160192954 | Brady et al. | Jul 2016 | A1 |
20160192955 | Brady et al. | Jul 2016 | A1 |
20160192956 | Brady et al. | Jul 2016 | A1 |
20160256180 | Vale et al. | Sep 2016 | A1 |
20160317168 | Brady et al. | Nov 2016 | A1 |
20170007264 | Cruise et al. | Jan 2017 | A1 |
20170007265 | Guo et al. | Jan 2017 | A1 |
20170020670 | Murray et al. | Jan 2017 | A1 |
20170020700 | Bienvenu | Jan 2017 | A1 |
20170027640 | Kunis et al. | Feb 2017 | A1 |
20170027692 | Bonhoeffer | Feb 2017 | A1 |
20170027725 | Argentine | Feb 2017 | A1 |
20170035436 | Morita | Feb 2017 | A1 |
20170035567 | Duffy | Feb 2017 | A1 |
20170042548 | Lam | Feb 2017 | A1 |
20170049596 | Schabert | Feb 2017 | A1 |
20170071737 | Kelley | Mar 2017 | A1 |
20170072452 | Monetti et al. | Mar 2017 | A1 |
20170079671 | Morero | Mar 2017 | A1 |
20170079680 | Bowman | Mar 2017 | A1 |
20170079766 | Wang | Mar 2017 | A1 |
20170079767 | Leon-Yip | Mar 2017 | A1 |
20170079812 | Lam et al. | Mar 2017 | A1 |
20170079817 | Sepetka | Mar 2017 | A1 |
20170079819 | Pung et al. | Mar 2017 | A1 |
20170079820 | Lam et al. | Mar 2017 | A1 |
20170086851 | Wallace | Mar 2017 | A1 |
20170086996 | Peterson et al. | Mar 2017 | A1 |
20170095259 | Tompkins et al. | Apr 2017 | A1 |
20170100126 | Bowman et al. | Apr 2017 | A1 |
20170100141 | Morero et al. | Apr 2017 | A1 |
20170100143 | Ryan M Granfield | Apr 2017 | A1 |
20170100183 | Iaizzo | Apr 2017 | A1 |
20170113023 | Steingisser et al. | Apr 2017 | A1 |
20170147765 | Mehta | May 2017 | A1 |
20170151032 | Loisel | Jun 2017 | A1 |
20170165062 | Rothstein | Jun 2017 | A1 |
20170165065 | Rothstein | Jun 2017 | A1 |
20170165454 | Tuohy | Jun 2017 | A1 |
20170172581 | Bose et al. | Jun 2017 | A1 |
20170172766 | Vong et al. | Jun 2017 | A1 |
20170172772 | Khenansho | Jun 2017 | A1 |
20170189033 | Sepetka et al. | Jul 2017 | A1 |
20170189035 | Porter | Jul 2017 | A1 |
20170215902 | Leynov et al. | Aug 2017 | A1 |
20170216484 | Cruise et al. | Aug 2017 | A1 |
20170224350 | Shimizu et al. | Aug 2017 | A1 |
20170224355 | Bowman et al. | Aug 2017 | A1 |
20170224467 | Piccagli et al. | Aug 2017 | A1 |
20170224511 | Dwork et al. | Aug 2017 | A1 |
20170224953 | Tran et al. | Aug 2017 | A1 |
20170231749 | Perkins et al. | Aug 2017 | A1 |
20170252064 | Staunton | Sep 2017 | A1 |
20170265983 | Lam et al. | Sep 2017 | A1 |
20170281192 | Tieu et al. | Oct 2017 | A1 |
20170281331 | Perkins et al. | Oct 2017 | A1 |
20170281344 | Costello | Oct 2017 | A1 |
20170281909 | Northrop et al. | Oct 2017 | A1 |
20170281912 | Melder | Oct 2017 | A1 |
20170290593 | Cruise et al. | Oct 2017 | A1 |
20170290654 | Sethna | Oct 2017 | A1 |
20170296324 | Argentine | Oct 2017 | A1 |
20170296325 | Marrocco et al. | Oct 2017 | A1 |
20170303939 | Greenhalgh | Oct 2017 | A1 |
20170303942 | Greenhalgh et al. | Oct 2017 | A1 |
20170303947 | Greenhalgh | Oct 2017 | A1 |
20170303948 | Wallace et al. | Oct 2017 | A1 |
20170304041 | Argentine | Oct 2017 | A1 |
20170304097 | Corwin et al. | Oct 2017 | A1 |
20170304595 | Nagasrinivasa | Oct 2017 | A1 |
20170312109 | Le | Nov 2017 | A1 |
20170312484 | Shipley et al. | Nov 2017 | A1 |
20170316561 | Helm et al. | Nov 2017 | A1 |
20170319826 | Bowman | Nov 2017 | A1 |
20170333228 | Orth et al. | Nov 2017 | A1 |
20170333236 | Greenan | Nov 2017 | A1 |
20170333678 | Bowman | Nov 2017 | A1 |
20170340383 | Bloom et al. | Nov 2017 | A1 |
20170348014 | Wallace | Dec 2017 | A1 |
20170348514 | Guyon et al. | Dec 2017 | A1 |
Number | Date | Country |
---|---|---|
202009001951 | Mar 2010 | DE |
102009056450 | Jun 2011 | DE |
102010010849 | Sep 2011 | DE |
10 2010 014778 | Oct 2011 | DE |
102010024085 | Dec 2011 | DE |
102011014586 | Sep 2012 | DE |
2301450 | Mar 2011 | EP |
2628455 | Aug 2013 | EP |
H0919438 | Jan 1997 | JP |
WO 9424926 | Nov 1994 | WO |
WO 9727808 | Aug 1997 | WO |
1997038631 | Oct 1997 | WO |
WO 9920335 | Apr 1999 | WO |
WO 9960933 | Dec 1999 | WO |
WO 9956801 | Apr 2000 | WO |
WO 0121077 | Mar 2001 | WO |
WO 2004056275 | Jul 2001 | WO |
WO 0202162 | Jan 2002 | WO |
WO 0211627 | Feb 2002 | WO |
WO 0243616 | Jun 2002 | WO |
WO 02070061 | Sep 2002 | WO |
WO 02094111 | Nov 2002 | WO |
WO 03002006 | Jan 2003 | WO |
WO 03030751 | Apr 2003 | WO |
WO 03051448 | Jun 2003 | WO |
WO 2004028571 | Apr 2004 | WO |
2005000130 | Jan 2005 | WO |
WO 2005027779 | Mar 2005 | WO |
WO 2006021407 | Mar 2006 | WO |
WO 2006031410 | Mar 2006 | WO |
WO 2006107641 | Oct 2006 | WO |
2006135823 | Dec 2006 | WO |
WO 2007054307 | May 2007 | WO |
WO 2007068424 | Jun 2007 | WO |
WO 2008034615 | Mar 2008 | WO |
2008051431 | May 2008 | WO |
WO 2008131116 | Oct 2008 | WO |
2009031338 | Mar 2009 | WO |
WO 2009076482 | Jun 2009 | WO |
WO 2009086482 | Jul 2009 | WO |
2009105710 | Aug 2009 | WO |
WO 2010010545 | Jan 2010 | WO |
WO 2010046897 | Apr 2010 | WO |
2010075565 | Jul 2010 | WO |
2010102307 | Sep 2010 | WO |
WO 2010146581 | Dec 2010 | WO |
WO 2011013556 | Feb 2011 | WO |
2011066961 | Jun 2011 | WO |
2011082319 | Jul 2011 | WO |
WO 2011095352 | Aug 2011 | WO |
2011110316 | Sep 2011 | WO |
WO 2012052982 | Apr 2012 | WO |
2012064726 | May 2012 | WO |
WO 2012081020 | Jun 2012 | WO |
2012110619 | Aug 2012 | WO |
2012120490 | Sep 2012 | WO |
WO 2012120490 | Sep 2012 | WO |
2013016435 | Jan 2013 | WO |
2013072777 | May 2013 | WO |
2013105099 | Jul 2013 | WO |
WO 2013109756 | Jul 2013 | WO |
2014081892 | May 2014 | WO |
2014139845 | Sep 2014 | WO |
2014169266 | Oct 2014 | WO |
2014178198 | Nov 2014 | WO |
2015061365 | Apr 2015 | WO |
2015134625 | Sep 2015 | WO |
2015179324 | Nov 2015 | WO |
2016010995 | Jan 2016 | WO |
Entry |
---|
US 6,348,062 B1, 02/2002, Hopkins (withdrawn) |
International Search Report and Written Opinion of International Application No. PCT/EP2014/054828, dated Sep. 15, 2014 (17 pages). |
Number | Date | Country | |
---|---|---|---|
20160015402 A1 | Jan 2016 | US |
Number | Date | Country | |
---|---|---|---|
61784940 | Mar 2013 | US |